110 related articles for article (PubMed ID: 34592531)
1. The serum fibroblast growth factor 21 is correlated with retinopathy in patients with type 2 diabetes mellitus.
Heidari Z; Hasanpour M
Diabetes Metab Syndr; 2021; 15(6):102296. PubMed ID: 34592531
[TBL] [Abstract][Full Text] [Related]
2. Serum fibroblast growth factor 21 concentrations in type 2 diabetic retinopathy patients.
Esteghamati A; Momeni A; Abdollahi A; Khandan A; Afarideh M; Noshad S; Nakhjavani M
Ann Endocrinol (Paris); 2016 Oct; 77(5):586-592. PubMed ID: 27106505
[TBL] [Abstract][Full Text] [Related]
3. Association between serum fibroblast growth factor 21 level and sight-threatening diabetic retinopathy in Chinese patients with type 2 diabetes.
Jin S; Xia N; Han L
BMJ Open Diabetes Res Care; 2021 Mar; 9(1):. PubMed ID: 33789910
[TBL] [Abstract][Full Text] [Related]
4. The U-shaped relationship between fibroblast growth factor 21 and microvascular complication in type 2 diabetes mellitus.
Jung CH; Jung SH; Kim BY; Kim CH; Kang SK; Mok JO
J Diabetes Complications; 2017 Jan; 31(1):134-140. PubMed ID: 27839924
[TBL] [Abstract][Full Text] [Related]
5. Serum fibroblast growth factor 21 levels are correlated with the severity of diabetic retinopathy.
Lin Y; Xiao YC; Zhu H; Xu QY; Qi L; Wang YB; Li XJ; Zheng ML; Zhong RS; Zhang Y; Xu XD; Wu BL; Xu ZM; Lu XH
J Diabetes Res; 2014; 2014():929756. PubMed ID: 24895642
[TBL] [Abstract][Full Text] [Related]
6. Correlation of serum delta-like ligand-4 level with the severity of diabetic retinopathy.
Zhu Y; Hu J; Du X; Fang Q; Zhou Y; Chen K
BMC Endocr Disord; 2021 Aug; 21(1):157. PubMed ID: 34362349
[TBL] [Abstract][Full Text] [Related]
7. Increased serum periostin concentrations are associated with the presence of diabetic retinopathy in patients with type 2 diabetes mellitus.
Ding Y; Ge Q; Qu H; Feng Z; Long J; Wei Q; Zhou Q; Wu R; Yao L; Deng H
J Endocrinol Invest; 2018 Aug; 41(8):937-945. PubMed ID: 29349642
[TBL] [Abstract][Full Text] [Related]
8. Plasma level of miR-93 is associated with higher risk to develop type 2 diabetic retinopathy.
Zou HL; Wang Y; Gang Q; Zhang Y; Sun Y
Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1159-1166. PubMed ID: 28382439
[TBL] [Abstract][Full Text] [Related]
9. The relationship between serum levels of fibroblast growth factor 21 and diabetic retinopathy.
Mousavi Z; Bonakdaran S; Sahebkar A; Yaghoubi G; Yaghoubi MA; Davoudian N; Mohebbi M
EXCLI J; 2017; 16():1249-1256. PubMed ID: 29285020
[TBL] [Abstract][Full Text] [Related]
10. FGF21 and glycemic control in patients with T1D.
Rosell Rask S; Krarup Hansen T; Bjerre M
Endocrine; 2019 Sep; 65(3):550-557. PubMed ID: 31372821
[TBL] [Abstract][Full Text] [Related]
11. Plasma fibroblast growth factor 21 levels increase with ectopic fat accumulation and its receptor levels are decreased in the visceral fat of patients with type 2 diabetes.
Hong ES; Lim C; Choi HY; Lee YK; Ku EJ; Moon JH; Park KS; Jang HC; Choi SH
BMJ Open Diabetes Res Care; 2019; 7(1):e000776. PubMed ID: 31798902
[TBL] [Abstract][Full Text] [Related]
12. Role of Fetuin-A and vascular endothelial growth factor In type 2 diabetes mellitus patients without and with retinopathy.
Priya E; Jayashree K; Senthilkumar GP; Yasir M; Babu K R; Devi TD
Diabetes Metab Syndr; 2019; 13(4):2699-2703. PubMed ID: 31405696
[No Abstract] [Full Text] [Related]
13. Circulating AFABP, FGF21, and PEDF Levels as Prognostic Biomarkers of Sight-threatening Diabetic Retinopathy.
Lee CH; Lui DT; Cheung CY; Fong CH; Yuen MM; Woo YC; Chow WS; Wong IY; Xu A; Lam KS
J Clin Endocrinol Metab; 2023 Aug; 108(9):e799-e806. PubMed ID: 36856742
[TBL] [Abstract][Full Text] [Related]
14. Correlation between systemic S100A8 and S100A9 levels and severity of diabetic retinopathy in patients with type 2 diabetes mellitus.
Lim RR; Vaidya T; Gadde SG; Yadav NK; Sethu S; Hainsworth DP; Mohan RR; Ghosh A; Chaurasia SS
Diabetes Metab Syndr; 2019; 13(2):1581-1589. PubMed ID: 31336525
[TBL] [Abstract][Full Text] [Related]
15. Association of serum fibroblast growth factor 21 with diabetic complications and insulin dose in patients with type 1 diabetes mellitus.
Taniguchi H; Nirengi S; Ishihara K; Sakane N
PLoS One; 2022; 17(2):e0263774. PubMed ID: 35192641
[TBL] [Abstract][Full Text] [Related]
16. Fibroblast Growth Factor 21 and Fetuin-A in Obese Adolescents With and Without Type 2 Diabetes.
Reinehr T; Karges B; Meissner T; Wiegand S; Fritsch M; Holl RW; Woelfle J
J Clin Endocrinol Metab; 2015 Aug; 100(8):3004-10. PubMed ID: 26052728
[TBL] [Abstract][Full Text] [Related]
17. Circulating fibroblast growth factor 21 levels predict progressive kidney disease in subjects with type 2 diabetes and normoalbuminuria.
Lee CH; Hui EY; Woo YC; Yeung CY; Chow WS; Yuen MM; Fong CH; Xu A; Lam KS
J Clin Endocrinol Metab; 2015 Apr; 100(4):1368-75. PubMed ID: 25625802
[TBL] [Abstract][Full Text] [Related]
18. Distinct changes in serum fibroblast growth factor 21 levels in different subtypes of diabetes.
Xiao Y; Xu A; Law LS; Chen C; Li H; Li X; Yang L; Liu S; Zhou Z; Lam KS
J Clin Endocrinol Metab; 2012 Jan; 97(1):E54-8. PubMed ID: 22013098
[TBL] [Abstract][Full Text] [Related]
19. Role of Circulating Fibroblast Growth Factor 21 Measurement in Primary Prevention of Coronary Heart Disease Among Chinese Patients With Type 2 Diabetes Mellitus.
Lee CH; Woo YC; Chow WS; Cheung CYY; Fong CHY; Yuen MMA; Xu A; Tse HF; Lam KSL
J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28588089
[TBL] [Abstract][Full Text] [Related]
20. The performance of a diabetic retinopathy risk score for screening for diabetic retinopathy in Chinese overweight/obese patients with type 2 diabetes mellitus.
Wang J; Chen H; Zhang H; Yang F; Chen RP; Li YB; Yang C; Lin SD; Chen LS; Liang GX; Cai DH
Ann Med; 2014 Sep; 46(6):417-23. PubMed ID: 25088608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
